MiNK Therapeutics, Inc. - Common Stock (INKT)
10.18
+0.22 (2.21%)
Mink Therapeutics Inc is a biotechnology company focused on developing innovative therapeutic solutions to address unmet medical needs
The company specializes in creating advanced treatments targeting various diseases and conditions by leveraging cutting-edge technologies in drug discovery and development. With a commitment to enhancing patient outcomes, Mink Therapeutics aims to bring novel therapies from the lab to the clinic, fostering improvements in healthcare through scientific research and collaboration.
![](https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp)
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via Chartmill · February 4, 2025
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · January 29, 2025
![](https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp)
Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.
Via Chartmill · January 28, 2025
![](/next-assets/images/schema-image-default.png)
Via Benzinga · November 13, 2024
![](https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp)
Curious to know what's happening on the US markets in the middle of the day on Tuesday? Join us as we explore the top gainers and losers in today's session.
Via Chartmill · January 28, 2025
![](https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp)
Today's session on Tuesday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Via Chartmill · January 28, 2025
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · October 4, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
INKT stock results show that MiNK Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · August 13, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
INKT stock results show that MiNK Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
Via InvestorPlace · May 14, 2024
![](https://cdn.benzinga.com/files/images/story/2024/05/13/Stock--chart-image-JPG.jpeg?width=1200&height=800&fit=crop)
MiNK Therapeutics shares are trading higher Monday after the clinical-stage biopharmaceutical company announced private placement financing of $5.8 million.
Via Benzinga · May 13, 2024
![](https://cdn.benzinga.com/files/images/story/2024/04/05/image13_0.jpg?width=1200&height=800&fit=crop)
Shares of Byrna Technologies Inc. (NASDAQBYRN) rose sharply during Friday’s session after the company reported better-than-expected first-quarter revenue, and announced a CFO transition.
Via Benzinga · April 5, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · April 5, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
INKT stock results show that MiNK Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.
Via InvestorPlace · March 21, 2024
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
Companies Reporting Before The Bell • Creative Realities (NASDAQCREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million.
Via Benzinga · March 21, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · February 7, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · February 6, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · November 3, 2023
![](https://cdn.benzinga.com/files/images/story/2023/10/17/sacks_parente_golf_-_logo.jpg?width=1200&height=800&fit=crop)
The Dow Jones closed higher by more than 300 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Via Benzinga · October 17, 2023
![](https://cdn.benzinga.com/files/images/story/2023/10/09/image_7.jpg?width=1200&height=800&fit=crop)
The Dow Jones closed higher by around 290 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Via Benzinga · October 9, 2023
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · October 4, 2023
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · June 22, 2023